Inmazeb (REGN-EB3) antibodies target the Ebola virus glycoprotein (IMAGE)

La Jolla Institute for Immunology

Inmazeb (REGN-EB3) antibodies target the Ebola virus glycoprotein

Caption

The new study shows how three antibodies (light blue, dark blue, and yellow) used in Inmazeb (REGN-EB3) bind to different regions of the Ebola virus glycoprotein (grey) to combat infection. Image credit: Ethan MacKenzie (Phospho Biomedical Animation)

Credit

Ethan MacKenzie (Phospho Biomedical Animation)

Usage Restrictions

Must credit Ethan MacKenzie (Phospho Biomedical Animation) and La Jolla Institute for Immunology

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.